Early perfusion changes in patients with recurrent high-grade brain tumor treated with Bevacizumab: preliminary results by a quantitative evaluation

BACKGROUND: To determine whether early monitoring of the effects of bevacizumab in patients with recurrent high-grade gliomas, by a Perfusion Computed Tomography (PCT), may be a predictor of the response to treatment assessed through conventional MRI follow-up. METHODS: Sixteen patients were enrolle...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidiri, Antonello, Pace, Andrea, Fabi, Alessandra, Maschio, Marta, Latagliata, Gaetano Marco, Anelli, Vincenzo, Piludu, Francesca, Carapella, Carmine Maria, Giovinazzo, Giuseppe, Marzi, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583244/
https://www.ncbi.nlm.nih.gov/pubmed/22494770
http://dx.doi.org/10.1186/1756-9966-31-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583244/
https://www.ncbi.nlm.nih.gov/pubmed/22494770
http://dx.doi.org/10.1186/1756-9966-31-33

Ejemplares similares